Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Modafinil and sleep architecture in an inpatient-outpatient treatment study of cocaine dependence.

Morgan PT, Angarita GA, Canavan S, Pittman B, Oberleitner L, Malison RT, Mohsenin V, Hodges S, Easton C, McKee S, Bessette A, Forselius E.

Drug Alcohol Depend. 2016 Mar 1;160:49-56. doi: 10.1016/j.drugalcdep.2015.12.004. Epub 2016 Jan 8.

PMID:
26777774
2.

Development and psychometric validation of a novel patient survey to assess perceived quality of substance abuse treatment in South Africa.

Myers B, Govender R, Koch JR, Manderscheid R, Johnson K, Parry CD.

Subst Abuse Treat Prev Policy. 2015 Nov 6;10:44. doi: 10.1186/s13011-015-0040-3.

3.

Methyl supplementation attenuates cocaine-seeking behaviors and cocaine-induced c-Fos activation in a DNA methylation-dependent manner.

Wright KN, Hollis F, Duclot F, Dossat AM, Strong CE, Francis TC, Mercer R, Feng J, Dietz DM, Lobo MK, Nestler EJ, Kabbaj M.

J Neurosci. 2015 Jun 10;35(23):8948-58. doi: 10.1523/JNEUROSCI.5227-14.2015.

4.

Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder.

Howell LL, Cunningham KA.

Pharmacol Rev. 2015;67(1):176-97. doi: 10.1124/pr.114.009514. Review.

5.

Systematic evaluation of "compliance" to prescribed treatment medications and "abstinence" from psychoactive drug abuse in chemical dependence programs: data from the comprehensive analysis of reported drugs.

Blum K, Han D, Femino J, Smith DE, Saunders S, Simpatico T, Schoenthaler SJ, Oscar-Berman M, Gold MS.

PLoS One. 2014 Sep 23;9(9):e104275. doi: 10.1371/journal.pone.0104275. eCollection 2014.

6.

Milk thistle seed extract protects rat C6 astroglial cells from acute cocaine toxicity.

Badisa RB, Fitch-Pye CA, Agharahimi M, Palm DE, Latinwo LM, Goodman CB.

Mol Med Rep. 2014 Nov;10(5):2287-92. doi: 10.3892/mmr.2014.2524. Epub 2014 Aug 28.

7.

Motivation and readiness for drug treatment: differences by modality and special populations.

Melnick G, Hawke J, De Leon G.

J Addict Dis. 2014;33(2):134-47. doi: 10.1080/10550887.2014.909700.

8.

Time to relapse following treatment for methamphetamine use: a long-term perspective on patterns and predictors.

Brecht ML, Herbeck D.

Drug Alcohol Depend. 2014 Jun 1;139:18-25. doi: 10.1016/j.drugalcdep.2014.02.702. Epub 2014 Mar 12.

9.

What happens in treatment doesn't stay in treatment: cocaine abstinence during treatment is associated with fewer problems at follow-up.

Kiluk BD, Nich C, Witkiewitz K, Babuscio TA, Carroll KM.

J Consult Clin Psychol. 2014 Aug;82(4):619-27. doi: 10.1037/a0036245. Epub 2014 Mar 17.

10.

Toward empirical identification of a clinically meaningful indicator of treatment outcome: features of candidate indicators and evaluation of sensitivity to treatment effects and relationship to one year follow up cocaine use outcomes.

Carroll KM, Kiluk BD, Nich C, DeVito EE, Decker S, LaPaglia D, Duffey D, Babuscio TA, Ball SA.

Drug Alcohol Depend. 2014 Apr 1;137:3-19. doi: 10.1016/j.drugalcdep.2014.01.012. Epub 2014 Jan 31. Review.

11.

Substance abuse intensive outpatient programs: assessing the evidence.

McCarty D, Braude L, Lyman DR, Dougherty RH, Daniels AS, Ghose SS, Delphin-Rittmon ME.

Psychiatr Serv. 2014 Jun 1;65(6):718-26. doi: 10.1176/appi.ps.201300249. Review.

12.

The employment of nurses in publicly funded substance abuse treatment programs.

Knudsen HK, Abraham AJ.

J Addict Nurs. 2012 Oct;23(3):174-80. doi: 10.1097/JAN.0b013e31826f4c25.

13.

Factors in sustained recovery from cocaine dependence.

McKay JR, Van Horn D, Rennert L, Drapkin M, Ivey M, Koppenhaver J.

J Subst Abuse Treat. 2013 Aug;45(2):163-72. doi: 10.1016/j.jsat.2013.02.007. Epub 2013 Apr 2.

14.

Dissociated grey matter changes with prolonged addiction and extended abstinence in cocaine users.

Connolly CG, Bell RP, Foxe JJ, Garavan H.

PLoS One. 2013;8(3):e59645. doi: 10.1371/journal.pone.0059645. Epub 2013 Mar 18.

15.

Vaccines in the Treatment of Substance Abuse.

Shorter D, Kosten TR.

Focus (Am Psychiatr Publ). 2011 Dec 1;2011(9):25-30.

16.

Predictors of dropout from psychosocial treatment in opioid-dependent outpatients.

McHugh RK, Murray HW, Hearon BA, Pratt EM, Pollack MH, Safren SA, Otto MW.

Am J Addict. 2013 Jan;22(1):18-22. doi: 10.1111/j.1521-0391.2013.00317.x.

17.

Process predictors of the outcome of group drug counseling.

Crits-Christoph P, Johnson JE, Connolly Gibbons MB, Gallop R.

J Consult Clin Psychol. 2013 Feb;81(1):23-34. doi: 10.1037/a0030101. Epub 2012 Oct 29.

18.
19.

Cost-effectiveness of peer-delivered interventions for cocaine and alcohol abuse among women: a randomized controlled trial.

Ruger JP, Abdallah AB, Luekens C, Cottler L.

PLoS One. 2012;7(3):e33594. doi: 10.1371/journal.pone.0033594. Epub 2012 Mar 20. Erratum in: PLoS One. 2012;7(8): doi/10.1371/annotation/d9d8b547-8154-48a1-b527-d0c51285ed3c. Prah Ruger, Jennifer [corrected to Ruger, Jennifer Prah]..

20.

Treatment program operations and costs.

Broome KM, Knight DK, Joe GW, Flynn PM.

J Subst Abuse Treat. 2012 Mar;42(2):125-33. doi: 10.1016/j.jsat.2011.10.013. Epub 2011 Dec 5.

Items per page

Supplemental Content

Write to the Help Desk